Publications by authors named "Mark Lythgoe"

Claim this Profile
T
Tetrazine--cyclooctene ligated lanthanide conjugates for biomedical imaging.
Hongxuan Chen, William Lim Kee Chang, Grace T McMullon, Yichao Yu, Benjamin P Woolley, Mark F Lythgoe

Inorg Chem Front· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of the glymphatic system on α-synuclein propagation: the role of aquaporin-4.
Douglas M Lopes, Sophie K Llewellyn, Sheila E Bury, Jiazheng Wang, Jack A Wells, Mark F Lythgoe

Brain· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navitoclax acts synergistically with irradiation to induce apoptosis in preclinical models of H3K27M-altered diffuse midline glioma.
Ashley Vardon, Scott Haston, Hiba Hamdi, Grace Cooksley, Romain Guiho, Mark Francis Lythgoe

Sci Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axonal injury is a targetable driver of glioblastoma progression.
Melanie Clements, Wenhao Tang, Zan Florjanic Baronik, Holly Simpson Ragdale, Roger Oria, Mark F Lythgoe

Nature· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microvascular aberrations found in human polycystic kidneys are an early feature in a Pkd1 mutant mouse model.
Daniyal J Jafree, Charith Perera, Mary Ball, Daniele Tolomeo, Gideon Pomeranz, Mark F Lythgoe

Dis Model Mech· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual health and reproductive toxicity from cancer therapies.
David J Benjamin, Mark P Lythgoe

Lancet Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detecting glioblastoma infiltration beyond conventional imaging tumour margins using MTE-NODDI.
Saketh R Karamched, Dunja Gorup, Daniele Tolomeo, Lucy J Brooks, Ting Gong, Mark F Lythgoe

Imaging Neurosci (Camb)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registry.
David J Benjamin, Anshu Shrestha, Dimitra Fellman, Rosemary D Cress, Mark P Lythgoe

Prostate Cancer Prostatic Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Comfort to Cure: Re-Emphasizing Supportive and Palliative Care in Oncology.
David J Benjamin, Mark P Lythgoe

Clin Oncol (R Coll Radiol)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of interim oncology treatments introduced for solid cancers during the COVID-19 pandemic in England: a retrospective evidence-based analysis.
Mark P Lythgoe, Alica-Joana Emhardt, Huseyin Naci, Jonathan Krell, Richard Sullivan

Lancet Reg Health Eur· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Glymphatic inhibition exacerbates tau propagation in an Alzheimer's disease model.
Douglas M Lopes, Jack A Wells, Da Ma, Lauren Wallis, Daniel Park, Mark F Lythgoe

Alzheimers Res Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved tumour delivery of iron oxide nanoparticles for magnetic hyperthermia therapy of melanoma ultrasound guidance and In SPECT quantification.
P Stephen Patrick, Daniel J Stuckey, Huachen Zhu, Tammy L Kalber, Haadi Iftikhar, Mark F Lythgoe

Nanoscale· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel endoscopic scoring system for immune mediated colitis: a multicenter retrospective study of 674 patients.
Yinghong Wang, Hamzah Abu-Sbeih, Tenglong Tang, Malek Shatila, David Faleck, Mark Lythgoe

Gastrointest Endosc· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access divergence to new cancer medicines in the United Kingdom.
Mark P Lythgoe, Sarah Blagden, Susannah Stanway, Richard Sullivan

Eur J Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
As bleak as it sounds? Analysing trends in oncology clinical trial initiation in the UK from 2010 to 2022.
Alexander David VanHelene, Matthew J Hadfield, Dario Trapani, Jeremy Lyle Warner, Mark P Lythgoe

BMJ Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulations.
Matthew J Hadfield, David J Benjamin, Jonathan Krell, Jeremy Warner, Mark P Lythgoe

Trends Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Implications of FDA's marketing authorization of hereditary cancer testing.
David J Benjamin, Mark P Lythgoe, Arash Rezazadeh Kalebasty

J Cancer Policy· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifileucel: the first cellular therapy approved for solid tumours.
Max Julve, Mark P Lythgoe, James Larkin, Andrew J S Furness

Trends Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in cardiac-driven perivascular fluid movement around the MCA in a pharmacological model of acute hypertension detected with non-invasive MRI.
Phoebe G Evans, Maria Sajic, Yichao Yu, Ian F Harrison, Patrick S Hosford, Mark F Lythgoe

J Cereb Blood Flow Metab· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hollywood's Take on Oncology: Portrayal of Cancer in Movies, 2010-2020.
David J Benjamin, Mark P Lythgoe, Arash Rezazadeh Kalebasty

JCO Oncol Pract· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glymphatic inhibition exacerbates tau propagation in an Alzheimer's disease model.
Douglas M Lopes, Jack A Wells, Da Ma, Lauren Wallis, Daniel Park, Mark F Lythgoe

Alzheimers Res Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
X-Ray Visible Protein Scaffolds by Bulk Iodination.
Carlos Flechas Becerra, Lady V Barrios Silva, Ebtehal Ahmed, Joseph C Bear, Zhiping Feng, Mark F Lythgoe

Adv Sci (Weinh)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human mutations in implicated in GABAergic synapse development in mice.
Stephanie Efthymiou, Wenyan Han, Muhammad Ilyas, Jun Li, Yichao Yu, Mark F Lythgoe

Front Mol Neurosci· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diversity of thought: public perceptions of genetic testing across ethnic groups in the UK.
Benjamin H L Harris, Caitlin McCabe, Hana Shafique, Simon Lammy, Laura Tookman, Mark Lythgoe

J Hum Genet· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shortages of essential cancer medicines: who is responsible and what are the possible solutions?
Kristina Jenei, Mark P Lythgoe, Kerstin N Vokinger

Lancet Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis